Review



rotigotine  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    MedChemExpress rotigotine
    Rotigotine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rotigotine/product/MedChemExpress
    Average 93 stars, based on 4 article reviews
    rotigotine - by Bioz Stars, 2026-05
    93/100 stars

    Images



    Similar Products

    rotigotine  (MedChemExpress)
    93
    MedChemExpress rotigotine
    Rotigotine, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rotigotine/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    rotigotine - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    rotigotine  (Shanghai Yuanye Biochemicals)
    86
    Shanghai Yuanye Biochemicals rotigotine
    Synthesis and characterization of <t>Rotigotine-loaded</t> nanoparticles (RT-NPs). (a) Scheme for showing the preparative procedures for RT-NPs. The different mass ratio of rotigotine to PEG- b -PPG- b -PEG (average Mn 12,000) are set as seven groups, with the reaction volume hold constant in each group, the polymer maintaine a consistent concentration at 10 mg/mL in (b) and rotigotine concentration is fixed around 1 mg/mL in (c). (d) The mass ratio, reaction volume, and polymer concentration are consistent with (b) except for the use of polymer with a lower molecular weight (Mn 8400). (e) Entrapment efficiency of RT-NPs in (b)-(d).
    Rotigotine, supplied by Shanghai Yuanye Biochemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rotigotine/product/Shanghai Yuanye Biochemicals
    Average 86 stars, based on 1 article reviews
    rotigotine - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    dopamine agonist rotigotine  (Dawley Inc)
    86
    Dawley Inc dopamine agonist rotigotine
    Synthesis and characterization of <t>Rotigotine-loaded</t> nanoparticles (RT-NPs). (a) Scheme for showing the preparative procedures for RT-NPs. The different mass ratio of rotigotine to PEG- b -PPG- b -PEG (average Mn 12,000) are set as seven groups, with the reaction volume hold constant in each group, the polymer maintaine a consistent concentration at 10 mg/mL in (b) and rotigotine concentration is fixed around 1 mg/mL in (c). (d) The mass ratio, reaction volume, and polymer concentration are consistent with (b) except for the use of polymer with a lower molecular weight (Mn 8400). (e) Entrapment efficiency of RT-NPs in (b)-(d).
    Dopamine Agonist Rotigotine, supplied by Dawley Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dopamine agonist rotigotine/product/Dawley Inc
    Average 86 stars, based on 1 article reviews
    dopamine agonist rotigotine - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    rotigotine hydrochloride  (MedChemExpress)
    93
    MedChemExpress rotigotine hydrochloride
    Synthesis and characterization of <t>Rotigotine-loaded</t> nanoparticles (RT-NPs). (a) Scheme for showing the preparative procedures for RT-NPs. The different mass ratio of rotigotine to PEG- b -PPG- b -PEG (average Mn 12,000) are set as seven groups, with the reaction volume hold constant in each group, the polymer maintaine a consistent concentration at 10 mg/mL in (b) and rotigotine concentration is fixed around 1 mg/mL in (c). (d) The mass ratio, reaction volume, and polymer concentration are consistent with (b) except for the use of polymer with a lower molecular weight (Mn 8400). (e) Entrapment efficiency of RT-NPs in (b)-(d).
    Rotigotine Hydrochloride, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rotigotine hydrochloride/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    rotigotine hydrochloride - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    poly(2-ethyl-2-oxazoline) rotigotine  (Serina Therapeutics)
    90
    Serina Therapeutics poly(2-ethyl-2-oxazoline) rotigotine
    Synthesis and characterization of <t>Rotigotine-loaded</t> nanoparticles (RT-NPs). (a) Scheme for showing the preparative procedures for RT-NPs. The different mass ratio of rotigotine to PEG- b -PPG- b -PEG (average Mn 12,000) are set as seven groups, with the reaction volume hold constant in each group, the polymer maintaine a consistent concentration at 10 mg/mL in (b) and rotigotine concentration is fixed around 1 mg/mL in (c). (d) The mass ratio, reaction volume, and polymer concentration are consistent with (b) except for the use of polymer with a lower molecular weight (Mn 8400). (e) Entrapment efficiency of RT-NPs in (b)-(d).
    Poly(2 Ethyl 2 Oxazoline) Rotigotine, supplied by Serina Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/poly(2-ethyl-2-oxazoline) rotigotine/product/Serina Therapeutics
    Average 90 stars, based on 1 article reviews
    poly(2-ethyl-2-oxazoline) rotigotine - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    retigabine rtg  (MedChemExpress)
    93
    MedChemExpress retigabine rtg
    Synthesis and characterization of <t>Rotigotine-loaded</t> nanoparticles (RT-NPs). (a) Scheme for showing the preparative procedures for RT-NPs. The different mass ratio of rotigotine to PEG- b -PPG- b -PEG (average Mn 12,000) are set as seven groups, with the reaction volume hold constant in each group, the polymer maintaine a consistent concentration at 10 mg/mL in (b) and rotigotine concentration is fixed around 1 mg/mL in (c). (d) The mass ratio, reaction volume, and polymer concentration are consistent with (b) except for the use of polymer with a lower molecular weight (Mn 8400). (e) Entrapment efficiency of RT-NPs in (b)-(d).
    Retigabine Rtg, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retigabine rtg/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    retigabine rtg - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    rotigotine  (Kolster Methods)
    90
    Kolster Methods rotigotine
    The flow diagram of selecting <t>Rotigotine-related</t> AEs from FAERS database
    Rotigotine, supplied by Kolster Methods, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rotigotine/product/Kolster Methods
    Average 90 stars, based on 1 article reviews
    rotigotine - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Synthesis and characterization of Rotigotine-loaded nanoparticles (RT-NPs). (a) Scheme for showing the preparative procedures for RT-NPs. The different mass ratio of rotigotine to PEG- b -PPG- b -PEG (average Mn 12,000) are set as seven groups, with the reaction volume hold constant in each group, the polymer maintaine a consistent concentration at 10 mg/mL in (b) and rotigotine concentration is fixed around 1 mg/mL in (c). (d) The mass ratio, reaction volume, and polymer concentration are consistent with (b) except for the use of polymer with a lower molecular weight (Mn 8400). (e) Entrapment efficiency of RT-NPs in (b)-(d).

    Journal: Fundamental Research

    Article Title: Intranasal delivery of rotigotine to the brain for treating Parkinson’s disease

    doi: 10.1016/j.fmre.2025.02.004

    Figure Lengend Snippet: Synthesis and characterization of Rotigotine-loaded nanoparticles (RT-NPs). (a) Scheme for showing the preparative procedures for RT-NPs. The different mass ratio of rotigotine to PEG- b -PPG- b -PEG (average Mn 12,000) are set as seven groups, with the reaction volume hold constant in each group, the polymer maintaine a consistent concentration at 10 mg/mL in (b) and rotigotine concentration is fixed around 1 mg/mL in (c). (d) The mass ratio, reaction volume, and polymer concentration are consistent with (b) except for the use of polymer with a lower molecular weight (Mn 8400). (e) Entrapment efficiency of RT-NPs in (b)-(d).

    Article Snippet: Dichloromethane was purchased from Chinasun Specialty Products Co., Ltd. Poly (ethylene glycol)-block-poly (propylene glycol)-block-poly(ethylene glycol) (PEG- b -PPG- b -PEG) with average molecular weights of 12,000 and 8000 were purchased from Shanghai Energy Chemical Co., Ltd. and Aladdin Co., Ltd. Dimethyl sulfoxide (DMSO) was purchased from Shanghai Aladdin Biochemical Technology Co., Ltd. Acetonitrile and Trifluoroacetic acid were purchased from Shanghai J&K Scientific Ltd. Rotigotine was purchased from Shanghai yuanye Bio-Technology Co., Ltd. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) hydrochloride was obtained from Dalian Meilun Biotech Co., Ltd. Phosphate buffer saline (0.01M, pH 7.2–7.4) was purchased from Solarbio Biotech.

    Techniques: Polymer, Concentration Assay, Molecular Weight

    Synthesis and characterization of RT-NPs. (a) TEM image and (b) size distribution histogram of RT-NPs. (c) Hydrodynamic size distribution profile of RT-NPs. (d) UV–Vis-NIR absorbance spectra of rotigotine and RT-NPs. (e) Hydrodynamic size and (f) UV–Vis-NIR absorbance spectra of RT-NPs in aqueous solution recorded against time.

    Journal: Fundamental Research

    Article Title: Intranasal delivery of rotigotine to the brain for treating Parkinson’s disease

    doi: 10.1016/j.fmre.2025.02.004

    Figure Lengend Snippet: Synthesis and characterization of RT-NPs. (a) TEM image and (b) size distribution histogram of RT-NPs. (c) Hydrodynamic size distribution profile of RT-NPs. (d) UV–Vis-NIR absorbance spectra of rotigotine and RT-NPs. (e) Hydrodynamic size and (f) UV–Vis-NIR absorbance spectra of RT-NPs in aqueous solution recorded against time.

    Article Snippet: Dichloromethane was purchased from Chinasun Specialty Products Co., Ltd. Poly (ethylene glycol)-block-poly (propylene glycol)-block-poly(ethylene glycol) (PEG- b -PPG- b -PEG) with average molecular weights of 12,000 and 8000 were purchased from Shanghai Energy Chemical Co., Ltd. and Aladdin Co., Ltd. Dimethyl sulfoxide (DMSO) was purchased from Shanghai Aladdin Biochemical Technology Co., Ltd. Acetonitrile and Trifluoroacetic acid were purchased from Shanghai J&K Scientific Ltd. Rotigotine was purchased from Shanghai yuanye Bio-Technology Co., Ltd. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) hydrochloride was obtained from Dalian Meilun Biotech Co., Ltd. Phosphate buffer saline (0.01M, pH 7.2–7.4) was purchased from Solarbio Biotech.

    Techniques:

    The flow diagram of selecting Rotigotine-related AEs from FAERS database

    Journal: BMC Pharmacology & Toxicology

    Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

    doi: 10.1186/s40360-025-00911-5

    Figure Lengend Snippet: The flow diagram of selecting Rotigotine-related AEs from FAERS database

    Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

    Techniques:

    Clinical characteristics of reports with rotigotine from the FAERS database

    Journal: BMC Pharmacology & Toxicology

    Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

    doi: 10.1186/s40360-025-00911-5

    Figure Lengend Snippet: Clinical characteristics of reports with rotigotine from the FAERS database

    Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

    Techniques:

    Time to onset of Rotigotine-associated adverse events and Weibull distribution analysis

    Journal: BMC Pharmacology & Toxicology

    Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

    doi: 10.1186/s40360-025-00911-5

    Figure Lengend Snippet: Time to onset of Rotigotine-associated adverse events and Weibull distribution analysis

    Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

    Techniques:

    The signal strength of AEs related to rotigotine at the SOC level in the FAERS database was detected by four algorithms

    Journal: BMC Pharmacology & Toxicology

    Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

    doi: 10.1186/s40360-025-00911-5

    Figure Lengend Snippet: The signal strength of AEs related to rotigotine at the SOC level in the FAERS database was detected by four algorithms

    Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

    Techniques:

    Signal Strength of top20 AEs of Rotigotine at the PT Level in FAERS Database

    Journal: BMC Pharmacology & Toxicology

    Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

    doi: 10.1186/s40360-025-00911-5

    Figure Lengend Snippet: Signal Strength of top20 AEs of Rotigotine at the PT Level in FAERS Database

    Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

    Techniques:

    The top 30 most frequent adverse events for rotigotine excluding common medication co-usage at the PT level from FAERS data

    Journal: BMC Pharmacology & Toxicology

    Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

    doi: 10.1186/s40360-025-00911-5

    Figure Lengend Snippet: The top 30 most frequent adverse events for rotigotine excluding common medication co-usage at the PT level from FAERS data

    Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

    Techniques:

    The top 30 signal strength of adverse events of rotigotine ranked by the number of case reports at the PTs level in FAERS database

    Journal: BMC Pharmacology & Toxicology

    Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data

    doi: 10.1186/s40360-025-00911-5

    Figure Lengend Snippet: The top 30 signal strength of adverse events of rotigotine ranked by the number of case reports at the PTs level in FAERS database

    Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Stiasny-Kolster et al., a total of 84 skin reactions were documented among 66 (9.6%) of the patients.

    Techniques: